Specialist Perception of Severe Asthma in Korea: A Questionnaire Survey
- PMID: 33733643
- PMCID: PMC7984944
- DOI: 10.4168/aair.2021.13.3.507
Specialist Perception of Severe Asthma in Korea: A Questionnaire Survey
Abstract
The Working Group on Severe Asthma of the Korean Academy of Allergy and Clinical Immunology recently published an expert opinion paper on the management of severe asthma in Korea. When developing a consensus, the working group encountered several diagnostic and treatment issues and decided to perform a questionnaire survey of Korean specialists with regard to severe asthma. An e-mail with a uniform resource locator link to the questionnaire was sent to 121 asthma specialists, of whom 44.6% responded. The most commonly accepted definitions of severe asthma were a history of fatal exacerbation or an asthma-triggered need for mechanical ventilation, 3-4 oral corticosteroid (OCS) bursts/year, and maintenance of OCS therapy for 3-6 months per year. Before diagnosing severe asthma, most physicians contemplate chest computed tomography, seek to control chronic rhinosinusitis, and consider poor inhaler compliance. For patients with uncontrolled severe asthma accompanied by type 2 (T2)-high inflammation, most biologics available in Korea were considered appropriate, but gaps were apparent in terms of T2-low asthma treatments. These findings about specialist perception of diagnosis and treatment of severe asthma will inform the use of emerging new drugs and facilitate personalized therapy.
Keywords: Asthma; biological products; consensus; diagnosis; disease management; standards; surveys and questionnaires; therapeutics.
Copyright © 2021 The Korean Academy of Asthma, Allergy and Clinical Immunology · The Korean Academy of Pediatric Allergy and Respiratory Disease.
Conflict of interest statement
There are no financial or other issues that might lead to a conflict of interest.
Figures
References
-
- Chen S, Golam S, Myers J, Bly C, Smolen H, Xu X. Systematic literature review of the clinical, humanistic, and economic burden associated with asthma uncontrolled by GINA Steps 4 or 5 treatment. Curr Med Res Opin. 2018;34:2075–2088. - PubMed
-
- Ivanova JI, Bergman R, Birnbaum HG, Colice GL, Silverman RA, McLaurin K. Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma. J Allergy Clin Immunol. 2012;129:1229–1235. - PubMed
-
- Kim S, Kim J, Kim K, Kim Y, Park Y, Baek S, et al. Healthcare use and prescription patterns associated with adult asthma in Korea: analysis of the NHI claims database. Allergy. 2013;68:1435–1442. - PubMed
-
- Global Initiative for Asthma. Global strategy for asthma management and prevention, 2020. Fontana: GINA; 2020. [cited 2020 Sep 15]. Available from: www.ginasthma.org.
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
